Pfizer
Bob Lynch is an experienced leader in Quality Assurance and Contract Operations within the biopharmaceutical industry. Currently serving as Director and Team Leader for Contract Operations QA at Pfizer since March 2016, Lynch previously held the role of Senior Manager for Contract Operations QA-Biotech from July 2011 to February 2016. Prior to these positions, Lynch was a Quality Assurance Team Leader at Pfizer Biotechnology Ireland and a QC Team Leader at Pfizer Ireland Pharmaceuticals. Lynch's educational background includes a Postgraduate Certificate in Biopharmaceutical Engineering from University College Dublin, a Postgraduate Diploma in Pharmaceutical Manufacturing Technology from Trinity College Dublin, and a Bachelor's degree in Science with a focus on Microbiology, Biochemistry, and Genetics from University of Galway.
This person is not in any teams
This person is not in any offices
Pfizer
584 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.